Skip to content

Matthew Bruner, MD

NPI 1104486463ActiveIndividual· Internal Medicine, Interventional Cardiology· Salt Lake City, UT

Internal Medicine, Interventional Cardiology (MD) in Salt Lake City, Utah, licensed in UT and SC, with an NPI issued in June 2019. Part D covered 59 prescriptions written in 2024, 71% of them generic. Abbott Laboratories was the largest of 7 companies reporting payments in 2025, $277.90 in all, mostly food and beverage.

Overview

NPI1104486463
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 19, 2019
Last updated in NPPESJul 22, 2026
Certified by providerJul 22, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Interventional Cardiology Primary207RI0011X14282007-1205UT
Internal Medicine207R00000XLL82822SC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Interventional Cardiology (UT)

Part D prescriptions in 2024

Prescriptions (claims)59 · 99 30-day fills
Patients20
Total drug cost$9,774
Generic share71% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$277.90 · 13 payments from 7 companies
  • 2024$394.67 · 14 payments from 8 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$277.90 · 13 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Interventional Cardiology providers in Salt Lake City

All Internal Medicine, Interventional Cardiology providers in Utah →